Shawn M. Bauer

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Penglie Zhang, Wenrong Huang, Lingyan Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 108 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Total Synthesis of Motuporin (Nodularin-V)

Shawn M. Bauer, Robert W. Armstrong · Journal of the American Chemical Society · 1999 · 81 citations

Life Sciences, Biochemistry, Medicinal Chemistry +16

Novel 3-Oxa Lipoxin A₄ Analogues with Enhanced Chemical and Metabolic Stability Have Anti-inflammatory Activity in Vivo

William J. Guilford, John G. Bauman, Werner Skuballa et al. · Journal of Medicinal Chemistry · 2004 · 79 citations

Medicine, Pharmacokinetics, Pharmacology +13

Construction of combinatorial chemical libraries using a rapid and efficient solid phase synthesis based on a multicomponent condensation reaction

Sang Woong Kim, Shawn M. Bauer, Robert W. Armstrong · Tetrahedron Letters · 1998 · 26 citations

Pharmacy, Chemical Engineering, Chemistry +15

Synthesis and biological evaluation of menthol-based derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)

Bin Ye, Shawn M. Bauer, Brad O. Buckman et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12